Clinical benefit and tolerance profile of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis. Results from a double‐blind, randomized, vehicle‐controlled study
Philippe Massiot(L'Oréal (France)), Delphine Kérob(Galderma (France)), Sérgio Vañó-Galván(Instituto Cajal), Bianca Maria Piraccini(Azienda USL di Bologna), Wenyu Wu(Fudan University), Pascal Reygagne(Hôpital Saint-Louis), Lidia Rudnicka(Medical University of Warsaw), Stéphanie Leclerc‐Mercier(Institut Européen De La Qualité Totale), Daniel Fernandes Melo(Universidade do Estado do Rio de Janeiro), Virginie Rasmont(Institut Européen De La Qualité Totale)
Cited by 6
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial
|British Journal of Dermatology|2014|221
Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France
|Journal of the American Academy of Dermatology|2020|189
Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non‐neoplastic dermatoses): an expert consensus on behalf of the International Dermoscopy Society
|British Journal of Dermatology|2019|183
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
|Nature Communications|2019|121